| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/24/2004 | US6780886 Administering 2,5,7,8-tetramethyl-2-( beta-carboxyethyl)-6-hydroxychromane, or 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychromane; treating arteriosclerosis, disease caused by oxidated low density lipoprotein |
| 08/24/2004 | US6780885 Pharmacologically active compounds may be administered to vertebrates by diluting the formulation in the drinking water of the vertebrate |
| 08/24/2004 | US6780884 Derivating of tryptamine and analogous compounds and pharmaceutical formulations containing them |
| 08/24/2004 | US6780882 Substituted benzimidazole dosage forms and method of using same |
| 08/24/2004 | US6780881 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 08/24/2004 | US6780880 To measure, monitor and/or control proper isomeric ratio(s) within omeprazole |
| 08/24/2004 | US6780879 As antitumor agent |
| 08/24/2004 | US6780878 Antithrombotic amides |
| 08/24/2004 | US6780876 Composition for keeping away vermin |
| 08/24/2004 | US6780874 Autoimmune disease; antiinflammatory agents; antiproliferative agent |
| 08/24/2004 | US6780873 Urea substituted imidazoquinolines |
| 08/24/2004 | US6780870 Treatment of the pain (both chronic and acute), fever and inflammation of a variety of conditions and diseases mediated by cox-2 |
| 08/24/2004 | US6780869 Selective inhibitor of cox-2; antiinflammatory agent |
| 08/24/2004 | US6780868 Treatment of myocardial or peripheral ischaemia, cardiac insufficiency or pulmonary arterial hypertension |
| 08/24/2004 | US6780867 Thienopyrimidines |
| 08/24/2004 | US6780866 Analgesic composition and method |
| 08/24/2004 | US6780864 Piperazine and piperidine compounds |
| 08/24/2004 | US6780862 Such as amino-indazoles for treatment of central nervous system disorders |
| 08/24/2004 | US6780861 Azabicyclic carbamates and their use as α-7 nicotinic acetylcholine receptor agonists |
| 08/24/2004 | US6780859 For therapy of diabetes, obesity, impaired glucose tolerance, gastrointestinal disorders, hypertriglyceridemia, hypercholesteolemia, atherosclerotic disorders, or cardiovascular disorders |
| 08/24/2004 | US6780858 Hydroxyamidines and related compounds |
| 08/24/2004 | US6780855 Treating a patient suffering from an estrogen dependent-disease |
| 08/24/2004 | US6780854 Orally active androgens |
| 08/24/2004 | US6780852 Oxidized and reduced starch exhibits longer vascular half-life, slower degradation by amylase, and/or slower clearance from an animal than unmodified starch; parental injections |
| 08/24/2004 | US6780851 Treatment of disorders due to abnormal lipid metabolism, such as hypercholesterolaemia, atherosclerosis, hyperlipidaemia and obesity |
| 08/24/2004 | US6780849 Nitric-oxide releasing lipid molecules selected from phosphoglycerides, lipids having a sphingosine base as a backbone, a monoglyceride, a diglyceride, a glycosylacylglycerol and a sterol containing s-n=o, n-n=o or |
| 08/24/2004 | US6780839 Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) |
| 08/24/2004 | US6780838 Compounds for treating fungal pathologies of the oral cavity |
| 08/24/2004 | US6780836 Treating infection or ischemic wound in a mammal by administering relaxin, a hormone which induces secretion of vascular endothelial growth factor (vegf) |
| 08/24/2004 | US6780642 Association of SIM2 with cancer |
| 08/24/2004 | US6780640 Human carboxypeptidases and polynucleotides encoding the same |
| 08/24/2004 | US6780623 Low temperature expression cDNAs encoding fructan synthesizing enzymes and method of isolating the same |
| 08/24/2004 | US6780443 Combination of cooling, warming and tingling agents for such as mouthwashes; employs jambu oleoresin and/or spilanthol; long lasting |
| 08/24/2004 | US6780442 Efficient method for producing compositions enriched in anthocyanins |
| 08/24/2004 | US6780439 Solution for the treatment of skin sores and wounds, consisting of cedar leaf oil, zinc oxide ointment, calamine lotion and an ointment base, may be applied to a sore or wound to promote healing and reduce scarring |
| 08/24/2004 | US6780436 Solid oral pharmaceutical formulation of modified release that contains an acid labile benzimidazole compound |
| 08/24/2004 | US6780435 Pellet comprising inert core component, omeprazole, surface active agent, filler, alkaline agent, binder and single layer of enteric coating |
| 08/24/2004 | US6780433 Using high-shear aqueous wet granulation with fluid-bed drying to form tablets of olanzapine having polymer coating; stability and prevents discoloration; for treatment of schizophrenia, mild anxiety, gastrointestinal disorders, and |
| 08/24/2004 | US6780432 Composed of such as metformin and having pioglitazone hydrochloride coating; synergistic controlled release action in single dosage |
| 08/24/2004 | US6780430 Stabilzation method of nano-sized emulsion using tocopheryl derivatives and external application for skin containing the same |
| 08/24/2004 | US6780429 With 2'-5' phosphodiester bond content up to 3%; maintains pharmacological action while reducing toxicity |
| 08/24/2004 | US6780426 Method and apparatus for improved heat controlled administration of pharmaceuticals |
| 08/24/2004 | US6780414 Methods of identifying bacterial genes that are incompatible with bacterial pathogenicity, and the use of such genes, such as cada, to reduce pathogenicity in a bacteria or to combat pathogenic bacterial infections |
| 08/24/2004 | US6780406 Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene |
| 08/24/2004 | US6780400 Delivery of antiemetics through an inhalation route |
| 08/24/2004 | US6780399 Delivery of stimulants through an inhalation route |
| 08/24/2004 | US6780398 Aqueous nasal formulation |
| 08/24/2004 | US6780324 Preparation of sterile stabilized nanodispersions |
| 08/24/2004 | CA2347336C A1 adenosine receptor agonists |
| 08/24/2004 | CA2334415C Compositions for increasing energy in vivo |
| 08/24/2004 | CA2323213C Treatment of respiratory disease and otitis media |
| 08/24/2004 | CA2313122C Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents |
| 08/24/2004 | CA2293711C Benzo(5,6)cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors |
| 08/24/2004 | CA2285733C Process for preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof |
| 08/24/2004 | CA2258013C Substituted benzylidene indenyl formamides, acetamides and propionamides |
| 08/24/2004 | CA2201784C Method and formulation of stimulating nitric oxide synthesis |
| 08/24/2004 | CA2178473C Flunisolide aerosol formulations |
| 08/24/2004 | CA2143610C Use of norastemizole for the treatment of allergic disorders |
| 08/24/2004 | CA2098256C Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals |
| 08/24/2004 | CA2065051C Improved use of .beta.2 bronchodilator drugs |
| 08/19/2004 | WO2004070057A2 Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long qt syndrome |
| 08/19/2004 | WO2004070044A1 Biologically-active-molecule-enriched photosynthetic micro-organisms, preparation method thereof and uses of same |
| 08/19/2004 | WO2004070034A2 Oligonucleotides directed against a survivin gene and use thereof |
| 08/19/2004 | WO2004070012A2 Cell-killing molecules and methods of use thereof |
| 08/19/2004 | WO2004070008A2 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors |
| 08/19/2004 | WO2004070002A2 Cell lines and host nucleic acid sequences related to infectious disease |
| 08/19/2004 | WO2004070000A2 Htlv-i-cell binding and inhibition |
| 08/19/2004 | WO2004069992A2 Oligomeric compounds for the modulation of ras expression |
| 08/19/2004 | WO2004069991A2 Oligomeric compounds for the modulation of survivin expression |
| 08/19/2004 | WO2004069898A1 Polymer guanidine derivatives as a cytostatic medicament |
| 08/19/2004 | WO2004069855A1 Novel glycosyl transferase with consideration of activity expression mechanism and method of producing the same |
| 08/19/2004 | WO2004069854A1 Novel anhydrolide derivatives having antibacterial activity |
| 08/19/2004 | WO2004069852A1 Avermectins substituted in the 4” and 4’-positions having pesticidal properties |
| 08/19/2004 | WO2004069840A2 Production of tetrahydroquinoline benzofurans |
| 08/19/2004 | WO2004069837A1 Pyrazolo`1,5-a!`1,3,5!triazine derivatives as cannabinoid receptor ligands |
| 08/19/2004 | WO2004069834A1 Tricyclic compound, process for producing the same, and use |
| 08/19/2004 | WO2004069833A1 Fused-ring pyridine derivative, process for producing the same, and use |
| 08/19/2004 | WO2004069832A2 Antibacterial agents |
| 08/19/2004 | WO2004069824A1 Pyrazole derivative |
| 08/19/2004 | WO2004069823A1 Inhibitors of histone deacetylase |
| 08/19/2004 | WO2004069822A1 Composition for inhibiting steroid side effect |
| 08/19/2004 | WO2004069813A1 Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands |
| 08/19/2004 | WO2004069810A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 08/19/2004 | WO2004069809A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 08/19/2004 | WO2004069806A2 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds |
| 08/19/2004 | WO2004069805A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists |
| 08/19/2004 | WO2004069798A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 08/19/2004 | WO2004069796A2 Process for producing levetiracetam |
| 08/19/2004 | WO2004069794A2 New arylpiperazinyl compounds |
| 08/19/2004 | WO2004069793A2 Novel 2-substituted cyclic amines as calcium sensing receptor modulators |
| 08/19/2004 | WO2004069339A1 Treatment for attention-deficit hyperactivity disorder |
| 08/19/2004 | WO2004069338A1 Use of combinations of h1 and h3 histamine receptor antagonists for the preparation of a medicament for the treatment of allergic skin and allergic ocular conditions |
| 08/19/2004 | WO2004069286A2 Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof |
| 08/19/2004 | WO2004069280A1 Pharmaceutical inclusion complexes containing a steroid and optionally an antibacterial agent |
| 08/19/2004 | WO2004069278A1 Hardenable thermally responsive compositions |
| 08/19/2004 | WO2004069277A1 Stable dispersion of solid particles comprising a water-insoluble pyrazine compound |
| 08/19/2004 | WO2004069275A1 Ophthalmic drugs |
| 08/19/2004 | WO2004069268A1 REGENERATION AND NEOGENESIS OF RETINAL VISUAL CELL WITH Otx2 GENE |
| 08/19/2004 | WO2004069267A1 Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases |
| 08/19/2004 | WO2004069261A1 Process for producing antiherpesvirus preparation for external use |